Symptom-to-Balloon Time is a Strong Predictor of Adverse Events Following Primary Percutaneous Coronary Intervention: Results From the Australian Capital.

Slides:

Advertisements

Similar presentations

A Review of a Regional Primary Percutaneous Coronary Intervention Service, with a Focus on Door to Reperfusion Times: The 2012 Auckland/Northland Experience.

Advertisements

Pulmonary Vein Isolation Compared to Rate Control in Patients with Atrial Fibrillation: A Systematic Review and Meta-analysis Kaivan Vaidya, MBBS, Clare.

Pre - Transcatheter Aortic Valve Implantation Workup in the Cardiac Catheterisation Laboratory Sarah Zaman, MBBS, PhD, Robert Gooley, MBBS, Liam McCormick,

Characterisation of Myocardial Injury via T1 Mapping in Early Reperfused Myocardial Infarction and its Relationship with Global and Regional Diastolic.

Impact of New-generation Hybrid Imaging Technology on Radiation Dose during Percutaneous Coronary Interventions and Trans-femoral Aortic Valve Implantations:

Hydrogen Sulfide Inhibits Human Platelet Aggregation In Vitro in Part by Interfering Gap Junction Channels: Effects of ACS14, a Hydrogen Sulfide-releasing.

A Randomised Controlled Trial on the Effect of Nurse-Led Educational Intervention at the Time of Catheter Ablation for Atrial Fibrillation on Quality.

Volume 386, Issue 10006, Pages (November 2015)

Degradable Chitosan-Collagen Composites Seeded with Cells as Tissue Engineered Heart Valves Jian-Hua Fu, PhD, Man Zhao, MD, Yan-Rong Lin, BS, Xu-Dong.

Jonathon P. Fanning, MBBS, Stephen V. Cox, FRACP, Gregory M

Endoscopic Radial Artery Harvesting Does not Compromise Graft Patency for Coronary Artery Bypass Graft: A Meta Analysis of 2782 Patients Hong Bing Wu,

Heart, Lung and Circulation

Systematic Detection of Familial Hypercholesterolaemia in Primary Health Care: A Community Based Prospective Study of Three Methods Andrew B. Kirke,

Procedure-specific Cardiac Surgeon Volume associated with Patient outcome following Valve Surgery, but not Isolated CABG Surgery Stephanie L. Ch’ng,

Effects of Obstructive Carotid Artery Disease on Ocular Circulation and the Safety of Carotid Artery Stenting Mehmet Yunus Emiroglu, MD, Mert Evlice,

Previous coronary stents do not increase early and long-term adverse outcomes in patients undergoing off-pump coronary artery bypass grafting: A propensity-matched.

Right Ventricular Morphology and Function in Chronic Obstructive Pulmonary Disease Patients Living at High Altitude Tolga Sinan Güvenç, MD, Hatice Betül.

Jennifer A. Cowger, MD, Matthew A

Radiofrequency Ablation for Atrial Tachycardia and Atrial Flutter

Heart, Lung and Circulation

Electrocardiographic Eligibility for Subcutaneous Implantable Cardioverter Defibrillator: Evaluation during Bicycle Exercise Matteo Ziacchi, MD, PhD,

Retrospective Study of First-Generation Drug-Eluting Stents, Second-Generation Drug- Eluting Stents and Non-Drug Eluting Stent Methods in the Treatment.

Cost-effectiveness of a Population-based Lifestyle Intervention to Promote Healthy Weight and Physical Activity in Non-attenders of Cardiac Rehabilitation

Edward J. Davies, MBBS, Ben Clayton, MBChB, Ian Lines, Guy A

Cardiac Troponin and its Relationship to Cardiovascular Outcomes in Community Populations – A Systematic Review and Meta-analysis Julie Sze, MBBS, John.

Hulya Bayiz, Mert Dumantepe, Burak Teymen, Ibrahim Uyar

Long-term clinical outcome of elderly patients with acute coronary syndrome treated with early percutaneous coronary intervention: Insights from the BASE.

Nuclear Cardiology Practices and Radiation Exposure in the Oceania Region: Results From the IAEA Nuclear Cardiology Protocols Study (INCAPS) Sinjini.

Repeated Target Vessel Revascularization After Coronary Artery Bypass for In-Stent Restenosis Jung-Hwan Kim, MD, Seung Hyun Lee, MD, PhD, Hyun-Chel Joo,

Manuel Caceres, MD, Darryl S. Weiman, MD, JD

The impact of placing multiple grafts to each myocardial territory on long-term survival after coronary artery bypass grafting Danny Chu, MD, Faisal.

Jeevan Nagendran, MD, Colleen M. Norris, PhD, Michelle M

Missed Intrapulmonary Lymph Node Metastasis and Survival After Resection of Non- Small Cell Lung Cancer Matthew P. Smeltzer, PhD, Nicholas Faris, MDiv,

Metabolic Syndrome Affects Midterm Outcome After Coronary Artery Bypass Grafting Emiliano Angeloni, MD, Giovanni Melina, PhD, Umberto Benedetto, PhD,

Revascularization of Left Anterior Descending Artery With Drug-Eluting Stents: Comparison With Off-Pump Surgery Itzhak Herz, MD, Yaron Moshkovitz, MD,

Stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: A meta-analysis of comparative studies Hisato Takagi,

Peter K. Smith, MD The Journal of Thoracic and Cardiovascular Surgery

Latin American randomized trial of balloon angioplasty vs coronary stenting for small vessels (LASMAL): Immediate and long-term results Alfredo Rodriguez,

Effect of Perioperative Pirfenidone Treatment in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis Takekazu Iwata, MD, PhD, Shigetoshi Yoshida,

Cardiac Surgery in Jehovah's Witness Patients: Ten-Year Experience

David Badrudin, MD, Feras Khaliel, MD, Raymond Cartier, MD

Surgical Treatment for Octogenarians with Lung Cancer: Results from a Population- Based Series of 124 Patients Hes A.P. Brokx, MD, Otto Visser, MD, PhD,

Outcomes of surgery for young children with multivessel pulmonary vein stenosis Luis G. Quinonez, MD, Kimberlee Gauvreau, PhD, Michele Borisuk, NP, Christina.

Long-Term Survival of Patients With Ischemic Cardiomyopathy Treated by Coronary Artery Bypass Grafting Versus Medical Therapy Eric J. Velazquez, MD,

Off-Pump Coronary Artery Bypass Surgery Versus Percutaneous Coronary Intervention: A Meta-Analysis of Randomized and Nonrandomized Studies J. James Edelman,

Coronary artery bypass grafting is superior to first-generation drug-eluting stents for unprotected left main coronary artery disease: An updated meta-analysis.

Chris Dickhoff, MD, Max Dahele, MD, PhD, Sayed M

Early and long-term outcomes of coronary artery bypass grafting in patients with acute coronary syndrome versus stable angina pectoris Toshihiro Fukui,

Volume 7, Issue 11, (November 2010)

Competing risks need to be considered in survival analysis models for cardiovascular outcomes Marianne Huebner, PhD, Martin Wolkewitz, Dr Sc Hum, Maurice.

Association of Troponin Trends and Cardiac Morbidity and Mortality After On-Pump Cardiac Surgery Eckhard Mauermann, MD, MSc, Daniel Bolliger, MD, Jens.

Predictors for Early and Late Outcomes After Coronary Artery Bypass Grafting in Hemodialysis Patients Yoshiyuki Takami, MD, Kazuyoshi Tajima, MD, Wataru.

Impact of statin therapy on patients with coronary heart disease and aortic aneurysm or dissection Junichi Tazaki, MD, Takeshi Morimoto, MD, PhD, Ryuzo.

Complete Revascularization of the Three-Vessel Territories Using a Left Internal Thoracic Artery Composite Graft Ho Young Hwang, MD, PhD, Hong Chul Oh,

Current Clinical Outcomes of Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting Michael J. Mack, MD, Syma L. Prince, RN, Morley Herbert,

William M. Whited, MD, Paul Henley, BS, Erin M

Stent Versus Off-Pump Coronary Bypass Grafting in the Second-Generation Drug- Eluting Stent Era Gijong Yi, MD, PhD, Hyun-Chel Joo, MD, Young-Nam Youn,

Kaplan-Meier analysis for the MACE-free or VA-free survival in patients with definite CS (A and C) or suspected CS (B and D) stratified by localisation.

Early and Midterm Results of Off-Pump Coronary Artery Bypass Grafting

A. Thomas Pezzella, MD, Sari D

Michael Hsie, MD, Stefania Morbidini-Gaffney, MD, Leslie J

Kaplan–Meyer survival curve of 1313 patients following primary PCI

Nabin K. Shrestha, MD, MPH, Jennifer Jue, MD, Syed T

Resected Synchronous Primary Malignant Lung Tumors: A Population-Based Study Hans Rostad, MD, PhD, Trond-Eirik Strand, MD, Anne Naalsund, MD, Jarle Norstein,

Improved Long-Term Survival for Diabetic Patients With Surgical Versus Interventional Revascularization Paul Kurlansky, MD, Morley Herbert, PhD, Syma.

Sequential In Situ Left Internal Thoracic Artery Grafting to the Circumflex and Right Coronary Artery Areas Cihat Bakay, MD, Burak Onan, MD, Aşkin Ali.

Impact of Diabetes on Five-Year Outcomes of Patients With Multivessel Coronary Artery Disease Whady Hueb, MD, Bernard J. Gersh, MB, ChB, Fernando Costa,

Utilization and Outcomes of Unprotected Left Main Coronary Artery Stenting and Coronary Artery Bypass Graft Surgery Chuntao Wu, MD, PhD, Edward L. Hannan,

Hari Padmanabhan, MRCP, Matthew J. Brookes, PhD, Alan M

Magnus Dalén, MD, Torbjörn Ivert, MD, PhD, Martin J

Presentation transcript:

Symptom-to-Balloon Time is a Strong Predictor of Adverse Events Following Primary Percutaneous Coronary Intervention: Results From the Australian Capital Territory PCI Registry Jaya Chandrasekhar, MBBS, Paul Marley, Dip App Sci, Christopher Allada, MBBS, Darryl McGill, MBBS, PhD, Simon O’Connor, MBBS, Moyazur Rahman, MBBS, Ren Tan, MBBS, Ata Doost Hosseiny, MD, Bruce Shadbolt, PhD, Ahmad Farshid, BMBS Heart, Lung and Circulation Volume 26, Issue 1, Pages 41-48 (January 2017) DOI: 10.1016/j.hlc.2016.05.114 Copyright © 2016 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ) Terms and Conditions

Figure 1 Study Flow for 1002 primary PCI patients. Heart, Lung and Circulation 2017 26, 41-48DOI: (10.1016/j.hlc.2016.05.114) Copyright © 2016 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ) Terms and Conditions

Figure 2 Kaplan-Meier analysis for MACE-free survival stratified by symptom-to-balloon time (≤240 and >240minutes). MACE refers to major adverse cardiac events, a composite of death, reinfarction, stent thrombosis and target vessel revascularisation. Heart, Lung and Circulation 2017 26, 41-48DOI: (10.1016/j.hlc.2016.05.114) Copyright © 2016 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ) Terms and Conditions

Figure 3 Incidence of 1 year major adverse cardiac events (MACE) by symptom-to-balloon time (minutes). MACE was a composite of death, reinfarction, stent thrombosis and target vessel revascularisation. Heart, Lung and Circulation 2017 26, 41-48DOI: (10.1016/j.hlc.2016.05.114) Copyright © 2016 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ) Terms and Conditions

Figure 4 Analysis of components of treatment times in subgroups with prolonged symptom-to-balloon times compared with the reference group Treatment times are in minutes and presented as medians; FMC, first medical contact. Heart, Lung and Circulation 2017 26, 41-48DOI: (10.1016/j.hlc.2016.05.114) Copyright © 2016 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ) Terms and Conditions